Ado-Trastuzumab Emtansine-Induced Pulmonary Toxicity: A Single-Institution Retrospective Review

Ado-Trastuzumab Emtansine-Induced Pulmonary Toxicity: A Single-Institution Retrospective Review

Purpose: T-DM1 is an antibody drug conjugate with proven efficacy in metastatic breast cancer for progressive disease refractory to trastuzumab. Drug-induced pneumonitis is a rare serious potential adverse effect. The purpose of this review was to estimate the incidence of pulmonary toxicity at our...

Full description

Bibliographic Details
Main Authors: Heidi Egloff, Kelley M. Kidwell, Anne Schott
Format: Article
Language:English
Published: Karger Publishers 2018-08-01
Series:Case Reports in Oncology
Subjects:
Ado-trastuzumab emtansine
T-DM1
Pneumonitis
Pulmonary toxicity
Breast cancer
Online Access:https://www.karger.com/Article/FullText/491574

Similar Items

Similar Items